2016
DOI: 10.1155/2016/2075157
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge

Abstract: Hemangiopericytomas are vascular tumors with a susceptibility to arise anywhere in the human body. We present a case of a 68-year-old female with primary omental hemangiopericytoma and a two-time recurrence managed with surgery and close follow-up. The first recurrence was at 52 months and the second at 37 months following the prior presentation. No adjuvant chemotherapy or radiation therapy was administered. Given the widespread nature of the cell of origin, routine follow-up postoperatively with interval ima… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
3

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 21 publications
0
2
0
3
Order By: Relevance
“…Surgical excision is the main modality of treatment, even in recurrent cases. 2 Radiation therapy can be given in recurrent or malignant cases. Chemotherapy shows no significant benefit.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Surgical excision is the main modality of treatment, even in recurrent cases. 2 Radiation therapy can be given in recurrent or malignant cases. Chemotherapy shows no significant benefit.…”
Section: Discussionmentioning
confidence: 99%
“…1 Omental SFT-HPC is extremely rare, around 10% of all primary omental tumors. 2 The term HPC was first coined by Stout and Murray. Enzinger and Smith described the features of these tumors in details.…”
Section: Introductionmentioning
confidence: 99%
“…Çoğunlukla selim seyretmekle birlikte agresif seyreden formları da bulunur. Bu tümör ilk olarak 1937'de Schmidt tarafından tespit edilmiş, 1942'de Stout ve Murray tarafından tamamen tanımlanmıştır (1). Son zamanlarda perisitik diferansiasyonun çok az olguda gösterilmesi sebebiyle yeni sınıflamada "soliter fibröz tümör" tanısı gündeme gelmiştir (2).…”
unclassified
“…Tanı koyulan hastaların %30-50'sinde alt ekstremite tutulumu mevcuttur (3). Ortalama görülme yaşı sıklıkla 45-55 yaş arasında değişmekte olup, erkekler ve kadınlar arasında eşit bir dağılım gözlenmektedir (1).…”
unclassified
See 1 more Smart Citation